AAAAAA
Results:
1-12
|
Results: 12
Authors:
Molyneux, PD
Brex, PA
Fogg, C
Lewis, S
Middleditch, C
Barkhof, F
Sormani, MP
Filippi, M
Miller, DH
Citation: Pd. Molyneux et al., The precision of TI hypointense lesion volume quantification in multiple sclerosis treatment trials: a multicenter study, MULT SCLER, 6(4), 2000, pp. 237-240
Authors:
Molyneux, PD
Barker, R
Thomas, PK
King, RHM
Miller, DH
Citation: Pd. Molyneux et al., Non-systemic vasculitic neuropathy resenting with a painful polyradiculopathy: a case report, J NEUROL, 247(8), 2000, pp. 645-646
Authors:
Molyneux, PD
Miller, DH
Filippi, M
Yousry, T
Kappos, L
Gasperini, C
Ader, HJ
Barkhof, F
Citation: Pd. Molyneux et al., The use of magnetic resonance imaging in multiple sclerosis treatment trials: power calculations for annual lesion lend measurement, J NEUROL, 247(1), 2000, pp. 34-40
Authors:
Brex, PA
Parker, GJM
Leary, SM
Molyneux, PD
Barker, GJ
Davie, CA
Thompson, AJ
Miller, DH
Citation: Pa. Brex et al., Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations, J NE NE PSY, 68(5), 2000, pp. 627-632
Authors:
Molyneux, PD
Kappos, L
Polman, C
Pozzilli, C
Barkhof, F
Filippi, M
Yousry, T
Hahn, D
Wagner, K
Ghazi, M
Beckmann, K
Dahlke, F
Losseff, N
Barker, GJ
Thompson, AJ
Miller, DH
Citation: Pd. Molyneux et al., The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis, BRAIN, 123, 2000, pp. 2256-2263
Authors:
Sormani, MP
Molyneux, PD
Barkhof, F
Miller, DH
Filippi, M
Citation: Mp. Sormani et al., MRI enhancing lesion frequency from patients with MS enrolled in the placebo arms of clinical trials or in natural history studies, MAGN RES IM, 17(8), 1999, pp. 1236-1237
Authors:
Miller, DH
Molyneux, PD
Barker, GJ
MacManus, DG
Moseley, IF
Wagner, K
Citation: Dh. Miller et al., Effect of interferon-beta 1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: Results of a European multicenter, randomized, double blind, placebo-controlled trial, ANN NEUROL, 46(6), 1999, pp. 850-859
Authors:
Tubridy, N
Molyneux, PD
Moseley, IF
Miller, DH
Citation: N. Tubridy et al., The sensitivity of thin-slice fast spin echo, fast FLAIR and gadolinium-enhanced T1-weighted MRI sequences in detecting new lesion activity in multiple sclerosis, J NEUROL, 246(12), 1999, pp. 1181-1185
Authors:
Molyneux, PD
Miller, DH
Filippi, M
Yousry, TA
Radu, EW
Ader, HJ
Barkhof, F
Citation: Pd. Molyneux et al., Visual analysis of serial T2-weighted MRI in multiple sclerosis: intra- and interobserver reproducibility, NEURORADIOL, 41(12), 1999, pp. 882-888
Authors:
Paolillo, A
Coles, AJ
Molyneux, PD
Gawne-Cain, M
MacManus, D
Barker, GJ
Compston, DAS
Miller, DH
Citation: A. Paolillo et al., Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H, NEUROLOGY, 53(4), 1999, pp. 751-757
Authors:
Brex, PA
Gomez-Anson, B
Parker, GJM
Molyneux, PD
Miszkiel, KA
Barker, GJ
MacManus, DG
Davie, CA
Plant, GT
Miller, DH
Citation: Pa. Brex et al., Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis, J NEUR SCI, 166(1), 1999, pp. 16-22
Authors:
Sormani, MP
Molyneux, PD
Gasperini, C
Barkhof, F
Yousry, TA
Miller, DH
Filippi, M
Citation: Mp. Sormani et al., Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results, J NE NE PSY, 66(4), 1999, pp. 465-469
Risultati:
1-12
|